Give 15% off, earn 10% back on every order they place.
Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.

Delivers to EU in 11-14 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade MT-1. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
| Quantity | Price Each | Total | Savings |
|---|---|---|---|
| 1 unit | €27.99 | €27.99 | -- |
| 3+ | €26.59 | €79.77 | 5% off |
| 5+Most Popular | €25.19 | €125.96 | 10% off |
| 10+ | €23.79 | €237.92 | 15% off |
Free shipping on orders over €200
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
Reconstitution Required
This peptide ships lyophilized (dry powder) and requires bacteriostatic water to reconstitute before use. BAC water is sold separately.
99.3% average HPLC purity, verified by independent third-party testing
Janoshik report published when available
24h dispatch, EU-wide shipping from €4.99
Supplier batch specification on every product; independent Janoshik report on selected lots
Melanotan I (afamelanotide) is a linear synthetic analogue of alpha-MSH with high selectivity for MC1R (melanocortin-1 receptor) compared to Melanotan II. The selectivity distinction is pharmacologically significant: In research models, MT-1 primarily activates MC1R on melanocytes, driving eumelanin synthesis (melanocyte pigmentation), without the pronounced MC4R-mediated effects (e.g. arousal and broader melanocortin pathways studied in animal models) that characterize MT-2. For research isolating melanocyte biology and MC1R pharmacology from other melanocortin receptor effects, MT-1 is the more appropriate tool.
Afamelanotide has been characterized extensively in the literature: the linear alpha-MSH analogue has been studied for its MC1R-mediated photoprotective pharmacology in research models of erythropoietic protoporphyria (EPP), a photosensitivity phenotype linked to a heme synthesis defect. In such models, afamelanotide's MC1R-mediated melanin increase has been investigated as a route to photoprotection. This body of pharmacology research provides unusually complete characterization data for a research peptide.
Each vial contains 10mg. For reference, the afamelanotide implant formulation delivers 16mg over 60 days; research use typically employs subcutaneous injection for more controlled dosing.
| Parameter | Value |
|---|---|
| Compound | Melanotan I (afamelanotide, linear alpha-MSH analogue) |
| Amount per Vial | 10mg |
| Purity | ≥98% (supplier batch spec; 99.3% avg across independently tested lots) |
| Format | Lyophilized powder |
| Reconstitution | Bacteriostatic water |
| Storage | -20°C; 2-8°C after reconstitution, protect from light |
Store at -20°C and protect from light. Refrigerate after reconstitution at 2-8°C and use within 28 days. Stable for 24+ months as lyophilized powder under proper conditions.
MT-1 (afamelanotide) is a linear alpha-MSH analogue with preferential selectivity for MC1R, the melanocyte receptor that drives skin pigmentation. MT-2 (Melanotan II) is a cyclic analogue that is a non-selective melanocortin receptor agonist with significant activity at MC1R, MC3R, MC4R, and MC5R. The MC4R activity of MT-2 produces pro-erectile and appetite-suppressing effects in animal models that MT-1 largely lacks. For research specifically on melanocyte biology, photoprotection, or MC1R pharmacology, MT-1 is the more appropriate compound. For studying MC4R or mixed melanocortin receptor effects, MT-2 is used.
Erythropoietic protoporphyria (EPP) is a rare genetic disorder caused by deficient ferrochelatase activity, leading to accumulation of protoporphyrin IX in red blood cells and skin. When protoporphyrin IX absorbs UV light, it generates reactive oxygen species that drive phototoxicity. In research on this pathway, MT-1 (afamelanotide) increases eumelanin through MC1R activation, which absorbs UV light before it reaches photosensitizing protoporphyrin molecules. This melanin-shield mechanism is the basis for studying afamelanotide as a photoprotective tool compound in EPP research models.
Yes, Melanotan I and afamelanotide refer to the same compound. Afamelanotide is the INN (International Nonproprietary Name) used in regulatory contexts, while "Melanotan I" or "MT-1" is the commonly used research name. The compound is the same linear alpha-MSH analogue regardless of the name used. The implant formulation delivers it as a subcutaneous bioresorbable depot; research applications typically use reconstituted solution for injection.
Melanotan I is supplied for laboratory research use only. Not approved for general human use. Handle in compliance with institutional biosafety guidelines.
Researcher Confidence
Who actually tests this?
Selected lots are independently verified by Janoshik Analytical (Czech Republic) and published on the Janoshik public portal. Other lots ship with the supplier's batch specification. See /coa for the published wall.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI 54169956, VAT-registered. Sameday for Romania, TCE Worldwide for all cross-border EU and non-EU markets (UK, Switzerland, Norway, Iceland, Israel, Serbia). Delivery 1–14 business days depending on destination — exact window shown at checkout.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
10mgSAME FIELDResearch-grade PT-141. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
SAME FIELDMelanotan II (MT-2) is a synthetic cyclic heptapeptide analog of alpha-MSH with potent melanocortin receptor agonist activity. Binds MC1R, MC3R, MC4R, MC5R. Studied in research models for melanogenesis and energy homeostasis. Supplied as lyophilized powder, shipped to a ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). For research purposes only. Not for human consumption.
RESEARCHERS ALSO STUDIEDResearch-grade CJC-1295 Without DAC. ≥98% supplier batch specification; selected lots independently tested (99.3% avg across published reports). Lyophilized powder in sealed glass vial.
500mcgRESEARCHERS ALSO STUDIEDKPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been studied for its immunomodulatory signaling in gastrointestinal and immune biology research models. Alpha-MSH-derived immunomodulatory tripeptide Intestinal epithelial barrier and PepT1 transporter research NF-kB pathway modulation studies For research purposes only. Not for human consumption.